| BLOOD AND MARROW |
|
BRI
|
|
Agura, Edward, MD
|
|
006-150
|
Phase II Trial of Clofarabine with Parenteral Busulfan (Busulfex) Followed by Allogeneic Related or Unrelated Donor Transplantation for the Treatment of Hematologic Malignancies and Diseases.s
|
|
008-021
|
A Phase I Study of SGN-40 (anti-huCD40 mAb),Lenalidomide (Revlimid¨, cc-5013) and Dexamethasone in Patients with Multiple Myeloma (MM)..
|
|
008-258
|
A Randomized, Double Blind, Placebo Controlled Study Evaluating the Efficacy and Safety of Romiplostim Treatment of Thrombocytopenia in Subjects with Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
|
|
Agura, Edward, MD
|
|
003-215
|
A Phase III Randomized, Multicenter Trial Comparing G-CSF Mobilized Peripheral Blood Stem Cell with Marrow Transplantation from HLA Compatible Unrelated Donors, National Marrow Donor P
|
|
Agura, Edward, MD.
|
|
099-092
|
Study Filgrastim-Mobilized Peripheral Blood Stem Cells for Primary Allogeneic Transplantation with Unrelated Donors, National Marrow Donor Program
|
|
Berryman, Brian, MD
|
|
007-244
|
Phase II Randomized, Open-Label Clinical Trial of Tanespimycin (KOS-953) plus Bortezomib Compared to Bortezomib Alone in Patients with Multiple Myeloma in First Relapse
|
|
009-010
|
A Pivotal Study of SGN-35 in Treatment of Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma (ALCL)
|
|
009-011
|
A pivotal study of SGN-35 in treatment of Patients with relapsed or refractory Hodgkin Lymphoma (HL)
|
| |
|
Berryman, Brian, MD
|
|
008-273
|
A Phase II Trial of Romidepsin and Bortezomib for Multiple Myeloma Patients with Relapsed or Refractory Disease
|
|
Fay, Joseph W., MD
|
|
008-272
|
A Phase II Study of Monoclonal Antibody CT-011 in Patients with Diffuse Large B-Cell Lymphoma following Autologous Peripheral Blood Stem Cell Transplantation
|
|
Pineiro, Luis, MD
|
|
009-029
|
A Multicenter, Phase II Trial of Non-Myeloablative Conditioning and Transplantation of Umbilical Cord Blood (UCB) from Unrelated Donors for Patients with Hematologic Malignancies, National Cancer Institute
|
|
009-093
|
A Phase II Trial of Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed Follicular Non-Hodgkin's Lymphoma beyond First Complete Response
|
|
Pineiro, Luis, MD
|
|
008-188
|
A Multicenter, Phase II Trial of Non-Myeloablative Conditioning (NST) and Transplantation of partially HLA-Mismatched Bone Marrow for Patients with Hematologic Malignancies, National Cancer Institute
|
|
Vance, Estil, MD
|
|
007-225
|
A Double-Blind, Randomized, Stratified, Multicenter Trial evaluating conventional and high dose Oseltamivir in the treatment of immunocompromised Patients with influenza
| | BRAIN/CENTRAL NERVOUS SYSTEM |
|
BRI
|
|
Fink, Karen, MD, PhD
|
|
008-129
|
A Phase I/II, Multicenter, safety and efficacy Study evaluating intravenously administered 131-I-TM601 in Patients with Progressive and/or Recurrent Malignant Glioma
| | BREAST |
|
BRI
|
|
Dr. Ima Boobman
|
|
6969
|
Free mammograms offered; some actually accepted. Breasts located and examined, but by that time the mammogram had been forgotten. Hot chicks though.
|
|
